Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Shu, Sahara"'
Autor:
Shigeru Tadokoro, Yukitoshi Sakao, Hideo Yasuda, Akihiko Kato, Mitsushige Sugimoto, Hitomi Ichikawa, Naro Ohashi, Hisanori Azekura, Koji Sano, Ken Sugimoto, Fuyuki Yamashita, Daiki Sugiyama, Takahisa Furuta, Akira Shimomura, Shu Sahara, Ken Fukuta
Publikováno v:
Journal of Clinical Biochemistry and Nutrition. 64:91-95
Plasma ghrelin level is influenced by Helicobacter pylori (H. pylori) status and the severity of gastric mucosal atrophy, and the ghrelin level is associated with nutrition status in hemodialysis patients. Here, we investigated the efficacy of H. pyl
Autor:
Hideo Yasuda, Naro Ohashi, Shu Sahara, Ken Sugimoto, Hitomi Ichikawa, Akihiko Kato, Yukitoshi Sakao, Takahisa Furuta, Yoshihide Fujigaki, Mitsushige Sugimoto, Takayuki Tsuji
Publikováno v:
Therapeutic Apheresis and Dialysis. 23:65-72
Ghrelin is an orexigenic hormone mainly secreted by the stomach, and it decreases according to the severity of gastric atrophy. Ghrelin has multiple favorable functions, including protein anabolism enhancement, anti-inflammatory activity, and cardiov
Autor:
Akihiko Kato, Ken Sugimoto, Naro Ohashi, Takahisa Furuta, Hideo Yasuda, Mitsushige Sugimoto, Takuma Kagami, Yoshiaki Horio, Shu Sahara, Hitomi Ichikawa, Yukitoshi Sakao
Publikováno v:
Digestion. 97:163-169
Background: An optimum Helicobacter pylori-eradication regimen for hemodialysis patients is yet to be established because of different pharmacokinetics of amoxicillin involved between hemodialysis patients and healthy subjects. We investigated to est
Autor:
Yukitoshi Sakao, Hideo Yasuda, Naro Ohashi, Mitsushige Sugimoto, Shu Sahara, Akira Andoh, Ken Sugimoto, Hitomi Ichikawa, Takahisa Furuta
Publikováno v:
Digestion. 95:302-309
Introduction:Helicobacter pylori (H. pylori) infection is one of the major risk factors for gastrointestinal morbidity in hemodialysis patients. Primary end point is to investigate H. pylori infection rate in hemodialysis patients. As secondary end p
Autor:
Taketo Otsuka, Akira Andoh, Shigeki Bamba, Mitsushige Sugimoto, Osamu Inatomi, Hiromitsu Ban, Takahisa Furuta, Hitomi Ichikawa, Shu Sahara
Publikováno v:
Internal Medicine
Objective The Kyoto gastritis classification categorizes the endoscopic characteristics of Helicobacter pylori (H. pylori) infection-associated gastritis and identifies patterns associated with a high risk of gastric cancer. We investigated its effic
Autor:
Yukitoshi, Sakao, Naro, Ohashi, Mitsushige, Sugimoto, Hitomi, Ichikawa, Shu, Sahara, Takayuki, Tsuji, Akihiko, Kato, Yoshihide, Fujigaki, Ken, Sugimoto, Takahisa, Furuta, Hideo, Yasuda
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 23(1)
Ghrelin is an orexigenic hormone mainly secreted by the stomach, and it decreases according to the severity of gastric atrophy. Ghrelin has multiple favorable functions, including protein anabolism enhancement, anti-inflammatory activity, and cardiov
Autor:
Hitomi, Ichikawa, Mitsushige, Sugimoto, Yukitoshi, Sakao, Shu, Sahara, Naro, Ohashi, Koji, Sano, Shigeru, Tadokoro, Hisanori, Azekura, Akira, Shimomura, Fuyuki, Yamashita, Daiki, Sugiyama, Ken, Fukuta, Takahisa, Furuta, Akihiko, Kato, Ken, Sugimoto, Hideo, Yasuda
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
Plasma ghrelin level is influenced by Helicobacter pylori (H. pylori) status and the severity of gastric mucosal atrophy, and the ghrelin level is associated with nutrition status in hemodialysis patients. Here, we investigated the efficacy of H. pyl
Autor:
Mitsushige Sugimoto, Hitomi Ichikawa, Shu Sahara, Takuma Kagami, Takahiro Uotani, Takahisa Furuta
Publikováno v:
Alimentary Pharmacology & Therapeutics. 42:477-483
SummaryBackground Bacterial resistance of Helicobacter pylori to antibiotics is increasing and it often leads to failure of antibiotic treatment. A new sitafloxacin-based triple therapy was developed to counter this situation; the fluoroquinolone sit
Autor:
Takahisa Furuta, Shu Sahara, Mihoko Yamade, Hitomi Ichikawa, Mitsushige Sugimoto, Takuma Kagami, Moriya Iwaizumi, Yasushi Hamaya, Ken Sugimoto, Satoshi Osawa, Takahiro Uotani, Hiroaki Miyajima
Publikováno v:
Digestion. 91:277-285
Background: When administered at a standard dose, proton pump inhibitors (PPIs) do not always provide sufficient acid inhibition for all subjects, particularly in extensive metabolizers (EMs) of CYP2C19. Whether esomeprazole at a dose of 20 mg four t
Autor:
Shu, Sahara, Mitsushige, Sugimoto, Hitomi, Ichikawa, Takuma, Kagami, Yukitoshi, Sakao, Naro, Ohashi, Yoshiaki, Horio, Ken, Sugimoto, Akihiko, Kato, Takahisa, Furuta, Hideo, Yasuda
Publikováno v:
Digestion. 97(2)
An optimum Helicobacter pylori-eradication regimen for hemodialysis patients is yet to be established because of different pharmacokinetics of amoxicillin involved between hemodialysis patients and healthy subjects. We investigated to establish appro